Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1996 Apr;41(4):305–309. doi: 10.1046/j.1365-2125.1996.03097.x

Stimulatory as well as inhibitory effects of ethinyloestradiol on the metabolic clearances of propranolol in young women

T WALLE 1, T C FAGAN 2, U K WALLE 1, M J TOPMILLER 2
PMCID: PMC2042593  PMID: 8730976

Abstract

1 The metabolism of a single 80 mg oral dose of propranolol was determined in nine young women before and after administration of ethinyloestradiol alone (EE2) or in combination with norethindrone (OC).

2 Whereas the total clearance of propranolol (2713±404 ml min−1 (mean±s.e.mean)) was not significantly altered by either EE2 (3365±347 ml min−1) or the combined OC (2905±345 ml min−1), significant changes in all three primary metabolic pathways were observed.

3 The clearance through side-chain oxidation decreased from 345±55 ml min−1 to 262±33 ml min−1 after EE2 (P<0.05). A similar reduction of cytochrome P450 metabolism by EE2 has been observed for other drugs.

4 The clearance through glucuronidation increased from 364±61 ml min−1 to 625±117 ml min−1 after EE2 (P<0.01). Similar stimulation of glucuronic acid conjugation by EE2 has also been observed for other drugs.

5 The clearance through ring oxidation increased from 697±109 ml min−1 to 1280±162 ml min−1 after EE2 (P<0.01). This observation appears to be a novel finding with EE2 and cytochrome P450 metabolism.

6 The treatment with OC produced changes in propranolol's metabolic clearances which were qualitatively similar to those generated by EE2.

Keywords: ethinyloestradiol, propranolol, metabolism, women, oral contraceptives

Full Text

The Full Text of this article is available as a PDF (228.9 KB).


Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES